We expected that the plants containing the chemicals acting on all three targets, S5R1, S5R2, and AR, can be the new candidates for controlling the symptoms or diseases involving androgen metabolism, such as BPH and prostate cancer. The gene discussed is AR; the disease is benign prostatic hyperplasia.